Health
Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial – News-Medical.Net
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth’s Geisel School of Medicine and publi…
Reviewed by Emily Henderson, B.Sc.Sep 29 2020
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted among 650 adolescents in Tanzania, a nation with high rates of TB infection, and showed that the vaccine was safe and induced immune responses against the disease.
Tuberculosis is most common infectious disease cause of death in…
-
Noosa News15 hours agoHelp to make recycling stick
-
Noosa News21 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News24 hours agoHow do you choose a safe childcare centre?
-
Noosa News13 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban